GLUCAGON(GLUCAGON HYDROCHLORIDE) - 美国FDA药品数据库

药品名称	GLUCAGON
申请号	012122	产品号	001
活性成分	GLUCAGON HYDROCHLORIDE	市场状态	停止上市
剂型或给药途径	INJECTABLE;INJECTION	规格	EQ 1MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons
治疗等效代码		参比药物	否
批准日期	Approved Prior to Jan 1, 1982	申请机构	ELI LILLY AND CO
化学类型	New molecular entity (NME)	审评分类	Priority review drug

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
012122	043	AP	1998/06/26	Control Supplement
012122	042	AP	1997/09/23	Manufacturing Change or Addition
012122	041	AP	1998/01/08	Control Supplement
012122	040	AP	1997/04/18	Labeling Revision
012122	039	AP	1997/05/12	Labeling Revision
012122	038	AP	1996/11/07	Control Supplement
012122	037	AP	1996/12/13	Control Supplement
012122	036	AP	1995/12/15	Labeling Revision
012122	035	AP	1996/04/19	Manufacturing Change or Addition
012122	034	AP	1993/04/28	Labeling Revision
012122	033	AP	1991/11/19	Control Supplement
012122	032	AP	1990/10/01	Labeling Revision
012122	031	AP	1990/10/11	Labeling Revision
012122	030	AP	1990/10/04	Labeling Revision
012122	029	AP	1988/12/02	Labeling Revision
012122	028	AP	1988/09/30	Package Change
012122	027	AP	1988/01/05	Labeling Revision
012122	026	AP	1991/04/03	Manufacturing Change or Addition
012122	025	AP	1986/09/30	Labeling Revision
012122	022	AP	1985/10/17	Control Supplement
012122	022	AP	1985/10/17	Labeling Revision
012122	019	AP	1984/12/13	Labeling Revision
012122	018	AP	1984/08/09	Labeling Revision
012122	017	AP	1984/08/02	Control Supplement
012122	016	AP	1983/07/21	Labeling Revision
012122	015	AP	1981/10/09	Manufacturing Change or Addition
012122	014	AP	1981/06/15	General Efficacy (MarkIV)
012122	013	AP	1980/02/21	General Efficacy (MarkIV)
012122	012	AP	1979/11/27	General Efficacy (MarkIV)
012122	010	AP	1975/12/31	Control Supplement
012122	009	AP	1975/01/27	Control Supplement
012122	008	AP	1975/05/20	Control Supplement
012122	000	AP	1960/11/14	Approval